BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 22748003)

  • 1. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.
    Unemo M; Golparian D; Potočnik M; Jeverica S
    Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010.
    Unemo M; Golparian D; Hestner A
    Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014.
    Golparian D; Ohlsson A; Janson H; Lidbrink P; Richtner T; Ekelund O; Fredlund H; Unemo M
    Euro Surveill; 2014 Jul; 19(30):. PubMed ID: 25108533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia.
    Hustig A; Bell C; Waddell R
    Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report.
    van Dam AP; van Ogtrop ML; Golparian D; Mehrtens J; de Vries HJ; Unemo M
    Sex Transm Infect; 2014 Nov; 90(7):513-4. PubMed ID: 25114322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010.
    Unemo M; Golparian D; Syversen G; Vestrheim DF; Moi H
    Euro Surveill; 2010 Nov; 15(47):. PubMed ID: 21144442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.
    Y Chen M; Stevens K; Tideman R; Zaia A; Tomita T; Fairley CK; Lahra M; Whiley D; Hogg G
    J Antimicrob Chemother; 2013 Jun; 68(6):1445-7. PubMed ID: 23390207
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.
    Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY
    Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods.
    Tapsall J; Read P; Carmody C; Bourne C; Ray S; Limnios A; Sloots T; Whiley D
    J Med Microbiol; 2009 May; 58(Pt 5):683-687. PubMed ID: 19369534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study.
    Hananta IPY; De Vries HJC; van Dam AP; van Rooijen MS; Soebono H; Schim van der Loeff MF
    Sex Transm Infect; 2017 Nov; 93(7):467-471. PubMed ID: 28822976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
    Harry TC
    Int J STD AIDS; 2005 Jul; 16(7):520. PubMed ID: 16004640
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges in implementing the new BASHH guidelines for the management of gonorrhoea.
    Rodgers S; Murgatroyd M; Perez K; Kingston M; Lee V
    Int J STD AIDS; 2014 Feb; 25(2):145-7. PubMed ID: 23970641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UK national guideline for the management of gonorrhoea in adults, 2011.
    Bignell C; Fitzgerald M; ;
    Int J STD AIDS; 2011 Oct; 22(10):541-7. PubMed ID: 21998172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated pharyngeal Neisseria gonorrhoeae in heterosexual male contacts.
    Thomson-Glover R; Brown R; Edirisinghe DN
    Int J STD AIDS; 2013 Dec; 24(12):983-5. PubMed ID: 23970625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant
    Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H
    Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-resistant
    Poncin T; Fouere S; Braille A; Camelena F; Agsous M; Bebear C; Kumanski S; Lot F; Mercier-Delarue S; Ngangro NN; Salmona M; Schnepf N; Timsit J; Unemo M; Bercot B
    Euro Surveill; 2018 May; 23(21):. PubMed ID: 29845928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia.
    Read PJ; Limnios EA; McNulty A; Whiley D; Lahra MM
    Sex Health; 2013 Nov; 10(5):460-2. PubMed ID: 24028864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011.
    Unemo M; Golparian D; Stary A; Eigentler A
    Euro Surveill; 2011 Oct; 16(43):. PubMed ID: 22085601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant
    Golparian D; Rose L; Lynam A; Mohamed A; Bercot B; Ohnishi M; Crowley B; Unemo M
    Euro Surveill; 2018 Nov; 23(47):. PubMed ID: 30482267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.
    Unemo M
    BMC Infect Dis; 2015 Aug; 15():364. PubMed ID: 26293005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.